ETF收评：港股通创新药ETF领涨5.06%，180治理ETF领跌2.71%
news flash·2025-07-29 07:02
Group 1 - The Hong Kong Stock Connect innovative drug ETF (520880) led the gains with an increase of 5.06% [1] - The Huatai-PB innovative drug ETF (517120) rose by 4.95% [1] - The Tianhong innovative drug ETF (517380) increased by 4.56% [1] Group 2 - The 180 governance ETF (510010) was the biggest loser, declining by 2.71% [1] - The German ETF (159561) fell by 2.36% [1] - The French CAC40 ETF (513080) decreased by 2.16% [1]